Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Ospelt

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Arthritis Research & Therapy|September 14, 2006
Safety concerns on the development of novel therapeutic drugsCaroline Ospelt, Steffen Gay
Best Practice & Research. Clinical Rheumatology|May 6, 2008
The role of resident synovial cells in destructive arthritisCaroline Ospelt, Steffen Gay
The International Journal of Biochemistry & Cell Biology|October 21, 2009
TLRs and chronic inflammationCaroline Ospelt, Steffen Gay
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2007
Antirheumatic drugs and gene signaturesCaroline Ospelt, Steffen Gay
RMD Open|September 19, 2020
Do you tweet?: trailing the connection between Altmetric and research impact!Paul Studenic, Caroline Ospelt
Nature Reviews. Rheumatology|June 16, 2017
Why location matters - site-specific factors in rheumatic diseasesCaroline Ospelt, Mojca Frank-Bertoncelj
Nature Reviews. Rheumatology|August 12, 2016
Epigenetics: New insights into site-specific variations in RA and OACaroline Ospelt, Mojca Frank-Bertoncelj
Current Opinion in Rheumatology|April 5, 2008
Is there a future for small molecule drugs in the treatment of rheumatic diseases?Joanna Stanczyk, Caroline Ospelt, Steffen Gay
Seminars in Immunopathology|March 22, 2017
Epigenetics in the pathogenesis of RACaroline Ospelt, Steffen Gay, Kerstin Klein
Arthritis Research & Therapy|November 21, 2012
Epigenetic contributions in the development of rheumatoid arthritisKerstin Klein, Caroline Ospelt, Steffen Gay
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Arthritis Research & Therapy|September 14, 2006
Safety concerns on the development of novel therapeutic drugsCaroline Ospelt, Steffen Gay
Best Practice & Research. Clinical Rheumatology|May 6, 2008
The role of resident synovial cells in destructive arthritisCaroline Ospelt, Steffen Gay
The International Journal of Biochemistry & Cell Biology|October 21, 2009
TLRs and chronic inflammationCaroline Ospelt, Steffen Gay
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2007
Antirheumatic drugs and gene signaturesCaroline Ospelt, Steffen Gay
RMD Open|September 19, 2020
Do you tweet?: trailing the connection between Altmetric and research impact!Paul Studenic, Caroline Ospelt
Nature Reviews. Rheumatology|June 16, 2017
Why location matters - site-specific factors in rheumatic diseasesCaroline Ospelt, Mojca Frank-Bertoncelj
Nature Reviews. Rheumatology|August 12, 2016
Epigenetics: New insights into site-specific variations in RA and OACaroline Ospelt, Mojca Frank-Bertoncelj
Current Opinion in Rheumatology|April 5, 2008
Is there a future for small molecule drugs in the treatment of rheumatic diseases?Joanna Stanczyk, Caroline Ospelt, Steffen Gay
Seminars in Immunopathology|March 22, 2017
Epigenetics in the pathogenesis of RACaroline Ospelt, Steffen Gay, Kerstin Klein
Arthritis Research & Therapy|November 21, 2012
Epigenetic contributions in the development of rheumatoid arthritisKerstin Klein, Caroline Ospelt, Steffen Gay
Pageof 12